Fig. 1From: Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancerPercentage of patients with pathogenic or likely pathogenic mutation (positive), variants of uncertain significance (VUS) or no mutations (negative)Back to article page